DIG
TEVA icon

DeepCurrents Investment Group’s Teva Pharmaceuticals TEVA Stock Holding History

DeepCurrents Investment Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-13,204
Closed -$91K – 119
2019
Q3 		$91K Buy
13,204
+1,639
+14% +$12.6K 0.01% 87
2019
Q2 		$107K Buy
+11,565
New +$139K 0.01% 84

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

DeepCurrents Investment Group's TEVA Position: Q4 2019 in Review

DeepCurrents Investment Group sold out of Teva Pharmaceuticals (TEVA) in Q4 2019, closing a stake of 13,204 shares — an estimated $91K sold.

DeepCurrents Investment Group first reported a position in TEVA in Q2 2019 and held it in 2 quarters. The position peaked at $107K in Q2 2019. 436 funds tracked by Wall St. Rank hold TEVA as of Q4 2019.

  • DeepCurrents Investment Group reported no remaining Teva Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • DeepCurrents Investment Group sold 13,204 Teva Pharmaceuticals shares in Q4 2019, an estimated $91K.
  • DeepCurrents Investment Group first reported a position in Teva Pharmaceuticals in Q2 2019 and held it in 2 quarters.
  • DeepCurrents Investment Group's Teva Pharmaceuticals position peaked at $107K in Q2 2019.
  • 436 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2019.

Based on DeepCurrents Investment Group's 13F filing for Q4 2019, filed 14 Feb 2020.